Concepts (187)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Adipocytes | 7 | 2016 | 88 | 1.450 |
Why?
|
| Adipose Tissue | 7 | 2008 | 221 | 0.910 |
Why?
|
| Ovarian Neoplasms | 3 | 2022 | 267 | 0.890 |
Why?
|
| Genes, Tumor Suppressor | 1 | 2022 | 61 | 0.800 |
Why?
|
| Oncogenes | 1 | 2022 | 71 | 0.790 |
Why?
|
| Neoplasms | 3 | 2022 | 1667 | 0.730 |
Why?
|
| Holistic Health | 1 | 2020 | 10 | 0.710 |
Why?
|
| Carcinogens, Environmental | 1 | 2020 | 16 | 0.710 |
Why?
|
| Bone Morphogenetic Proteins | 3 | 2007 | 43 | 0.630 |
Why?
|
| Cell Lineage | 3 | 2008 | 146 | 0.620 |
Why?
|
| Environmental Exposure | 1 | 2020 | 269 | 0.600 |
Why?
|
| Obesity | 5 | 2019 | 1076 | 0.580 |
Why?
|
| Surface-Active Agents | 2 | 2019 | 57 | 0.560 |
Why?
|
| Inflammation | 2 | 2020 | 1030 | 0.560 |
Why?
|
| Hexoses | 1 | 2016 | 5 | 0.550 |
Why?
|
| Emulsifying Agents | 1 | 2016 | 5 | 0.550 |
Why?
|
| Petroleum Pollution | 1 | 2016 | 6 | 0.540 |
Why?
|
| Algorithms | 1 | 2022 | 1196 | 0.540 |
Why?
|
| Food | 1 | 2016 | 52 | 0.530 |
Why?
|
| Transcriptional Activation | 1 | 2016 | 226 | 0.510 |
Why?
|
| Apoptosis | 1 | 2022 | 1641 | 0.500 |
Why?
|
| Adipogenesis | 2 | 2016 | 17 | 0.450 |
Why?
|
| Nonmuscle Myosin Type IIA | 1 | 2012 | 4 | 0.430 |
Why?
|
| Oxidoreductases Acting on Sulfur Group Donors | 1 | 2012 | 20 | 0.420 |
Why?
|
| S100 Proteins | 1 | 2012 | 42 | 0.420 |
Why?
|
| Sympathetic Nervous System | 5 | 2006 | 81 | 0.390 |
Why?
|
| DNA Copy Number Variations | 2 | 2022 | 27 | 0.390 |
Why?
|
| Cell Line, Tumor | 4 | 2022 | 1851 | 0.380 |
Why?
|
| Signal Transduction | 6 | 2022 | 2689 | 0.340 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2012 | 300 | 0.340 |
Why?
|
| Dioctyl Sulfosuccinic Acid | 3 | 2019 | 15 | 0.330 |
Why?
|
| Norepinephrine | 4 | 2006 | 276 | 0.330 |
Why?
|
| Photoperiod | 2 | 2005 | 11 | 0.310 |
Why?
|
| Wnt Proteins | 1 | 2008 | 57 | 0.300 |
Why?
|
| Petroleum | 2 | 2016 | 14 | 0.260 |
Why?
|
| Aneuploidy | 2 | 2022 | 21 | 0.250 |
Why?
|
| PPAR gamma | 2 | 2016 | 95 | 0.250 |
Why?
|
| DNA Methylation | 1 | 2006 | 193 | 0.250 |
Why?
|
| Stem Cells | 1 | 2006 | 248 | 0.240 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 1173 | 0.230 |
Why?
|
| Mice | 10 | 2019 | 8474 | 0.210 |
Why?
|
| Nelfinavir | 1 | 2022 | 4 | 0.210 |
Why?
|
| Giant Cells | 1 | 2022 | 14 | 0.210 |
Why?
|
| Hydroxychloroquine | 1 | 2022 | 14 | 0.210 |
Why?
|
| Polyploidy | 1 | 2022 | 24 | 0.200 |
Why?
|
| Carboplatin | 1 | 2022 | 59 | 0.200 |
Why?
|
| Animals | 15 | 2019 | 20881 | 0.200 |
Why?
|
| Sirolimus | 1 | 2022 | 118 | 0.190 |
Why?
|
| 3T3-L1 Cells | 3 | 2016 | 30 | 0.190 |
Why?
|
| Genetic Heterogeneity | 1 | 2020 | 11 | 0.190 |
Why?
|
| Single-Cell Analysis | 1 | 2020 | 35 | 0.180 |
Why?
|
| Cricetinae | 6 | 2006 | 262 | 0.180 |
Why?
|
| PPAR delta | 1 | 2020 | 14 | 0.180 |
Why?
|
| Autophagy | 1 | 2022 | 208 | 0.180 |
Why?
|
| Phodopus | 5 | 2006 | 5 | 0.170 |
Why?
|
| Cyclooxygenase 2 | 1 | 2020 | 160 | 0.170 |
Why?
|
| Humans | 11 | 2022 | 68618 | 0.170 |
Why?
|
| Glutathione | 2 | 2012 | 343 | 0.170 |
Why?
|
| Bone Morphogenetic Protein 4 | 3 | 2007 | 17 | 0.160 |
Why?
|
| Metabolic Diseases | 1 | 2019 | 37 | 0.160 |
Why?
|
| Adiposity | 1 | 2019 | 88 | 0.160 |
Why?
|
| Dyslipidemias | 1 | 2019 | 98 | 0.150 |
Why?
|
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2020 | 240 | 0.150 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 154 | 0.150 |
Why?
|
| Cell Differentiation | 4 | 2015 | 1034 | 0.150 |
Why?
|
| Oleic Acid | 1 | 2016 | 40 | 0.140 |
Why?
|
| Retinoid X Receptor alpha | 1 | 2016 | 18 | 0.140 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2020 | 756 | 0.130 |
Why?
|
| HEK293 Cells | 1 | 2016 | 326 | 0.120 |
Why?
|
| Cell Count | 2 | 2006 | 248 | 0.120 |
Why?
|
| Cell Line | 3 | 2008 | 1752 | 0.120 |
Why?
|
| Mutation | 1 | 2020 | 1213 | 0.120 |
Why?
|
| Energy Metabolism | 2 | 2007 | 222 | 0.120 |
Why?
|
| Gene Expression Profiling | 2 | 2006 | 498 | 0.120 |
Why?
|
| RNA, Messenger | 3 | 2008 | 1664 | 0.120 |
Why?
|
| Adipose Tissue, Brown | 2 | 2004 | 8 | 0.110 |
Why?
|
| Models, Biological | 2 | 2008 | 981 | 0.110 |
Why?
|
| Models, Molecular | 2 | 2012 | 546 | 0.110 |
Why?
|
| S100 Calcium-Binding Protein A4 | 1 | 2012 | 15 | 0.110 |
Why?
|
| Protein Interaction Mapping | 1 | 2012 | 62 | 0.100 |
Why?
|
| Immunohistochemistry | 2 | 2012 | 1174 | 0.100 |
Why?
|
| Organ Size | 4 | 2005 | 242 | 0.100 |
Why?
|
| Cell Adhesion | 1 | 2012 | 324 | 0.100 |
Why?
|
| Gene Expression Regulation | 2 | 2008 | 1293 | 0.100 |
Why?
|
| Actins | 1 | 2012 | 249 | 0.100 |
Why?
|
| Carrier Proteins | 2 | 2006 | 597 | 0.090 |
Why?
|
| Transcription Factors | 2 | 2008 | 753 | 0.090 |
Why?
|
| Oxidation-Reduction | 1 | 2012 | 567 | 0.090 |
Why?
|
| Cell Movement | 1 | 2012 | 630 | 0.090 |
Why?
|
| Protein Binding | 1 | 2012 | 1027 | 0.080 |
Why?
|
| Protein Disulfide-Isomerases | 1 | 2009 | 27 | 0.080 |
Why?
|
| Lipolysis | 2 | 2005 | 13 | 0.080 |
Why?
|
| Up-Regulation | 2 | 2008 | 682 | 0.080 |
Why?
|
| Herpesvirus 1, Suid | 2 | 2006 | 2 | 0.080 |
Why?
|
| Thrombospondins | 1 | 2008 | 5 | 0.080 |
Why?
|
| beta Catenin | 1 | 2008 | 73 | 0.070 |
Why?
|
| Renin | 1 | 2007 | 96 | 0.070 |
Why?
|
| Pluripotent Stem Cells | 1 | 2008 | 42 | 0.070 |
Why?
|
| Dietary Fats | 1 | 2007 | 103 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2009 | 382 | 0.070 |
Why?
|
| Leptin | 2 | 2005 | 80 | 0.070 |
Why?
|
| Matrix Metalloproteinase 13 | 1 | 2006 | 24 | 0.070 |
Why?
|
| Embryonic Stem Cells | 1 | 2006 | 40 | 0.070 |
Why?
|
| Phenotype | 2 | 2007 | 947 | 0.070 |
Why?
|
| Matrix Metalloproteinase 3 | 1 | 2006 | 22 | 0.070 |
Why?
|
| Cell Nucleus | 1 | 2008 | 305 | 0.070 |
Why?
|
| Azacitidine | 1 | 2006 | 20 | 0.070 |
Why?
|
| Female | 5 | 2022 | 38074 | 0.070 |
Why?
|
| Adipose Tissue, White | 1 | 2006 | 7 | 0.070 |
Why?
|
| Parasympathetic Nervous System | 1 | 2006 | 14 | 0.070 |
Why?
|
| Vagus Nerve | 1 | 2006 | 90 | 0.070 |
Why?
|
| Adrenergic beta-3 Receptor Agonists | 1 | 2005 | 3 | 0.060 |
Why?
|
| Mesoderm | 1 | 2006 | 231 | 0.060 |
Why?
|
| Sympathectomy, Chemical | 1 | 2005 | 6 | 0.060 |
Why?
|
| Ethanolamines | 1 | 2005 | 33 | 0.060 |
Why?
|
| Pseudorabies | 1 | 2004 | 1 | 0.060 |
Why?
|
| Cyclic AMP | 1 | 2005 | 223 | 0.060 |
Why?
|
| Lipectomy | 1 | 2004 | 3 | 0.060 |
Why?
|
| Denervation | 1 | 2004 | 23 | 0.060 |
Why?
|
| Cell Size | 1 | 2004 | 76 | 0.060 |
Why?
|
| Promoter Regions, Genetic | 1 | 2006 | 615 | 0.060 |
Why?
|
| Prosencephalon | 1 | 2004 | 38 | 0.060 |
Why?
|
| Brain Stem | 1 | 2004 | 46 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 4 | 2019 | 2791 | 0.060 |
Why?
|
| Brain | 2 | 2005 | 2176 | 0.060 |
Why?
|
| Receptors, Adrenergic, beta-3 | 1 | 2002 | 4 | 0.050 |
Why?
|
| Cell Proliferation | 1 | 2006 | 1174 | 0.050 |
Why?
|
| Male | 7 | 2019 | 37321 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2005 | 1745 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2006 | 2673 | 0.050 |
Why?
|
| Neoplasm Grading | 1 | 2020 | 111 | 0.050 |
Why?
|
| Glucose Intolerance | 1 | 2019 | 36 | 0.040 |
Why?
|
| Membrane Proteins | 1 | 2002 | 617 | 0.040 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 120 | 0.030 |
Why?
|
| Mass Spectrometry | 1 | 2015 | 284 | 0.030 |
Why?
|
| Polymerase Chain Reaction | 1 | 2015 | 492 | 0.030 |
Why?
|
| Pregnancy | 1 | 2019 | 2334 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2015 | 1033 | 0.030 |
Why?
|
| Gene Expression | 2 | 2006 | 770 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2006 | 2083 | 0.020 |
Why?
|
| HL-60 Cells | 1 | 2009 | 50 | 0.020 |
Why?
|
| 4-Aminobenzoic Acid | 1 | 2009 | 30 | 0.020 |
Why?
|
| para-Aminobenzoates | 1 | 2009 | 27 | 0.020 |
Why?
|
| Azo Compounds | 1 | 2009 | 33 | 0.020 |
Why?
|
| Protein Folding | 1 | 2009 | 82 | 0.020 |
Why?
|
| Cysteine | 1 | 2009 | 112 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2009 | 99 | 0.020 |
Why?
|
| Structure-Activity Relationship | 1 | 2009 | 420 | 0.020 |
Why?
|
| Diacylglycerol O-Acyltransferase | 1 | 2007 | 2 | 0.020 |
Why?
|
| Basal Metabolism | 1 | 2007 | 22 | 0.020 |
Why?
|
| Thinness | 1 | 2007 | 14 | 0.020 |
Why?
|
| Amino Acid Sequence | 1 | 2009 | 1083 | 0.020 |
Why?
|
| Proteomics | 1 | 2009 | 246 | 0.020 |
Why?
|
| Rats | 2 | 2006 | 5300 | 0.020 |
Why?
|
| Molecular Sequence Data | 1 | 2009 | 1447 | 0.020 |
Why?
|
| Angiotensin II | 1 | 2007 | 220 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 2006 | 272 | 0.020 |
Why?
|
| Vasoactive Intestinal Peptide | 1 | 2006 | 19 | 0.020 |
Why?
|
| Mice, Obese | 1 | 2006 | 33 | 0.020 |
Why?
|
| Cholinergic Fibers | 1 | 2006 | 27 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2006 | 254 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type I | 1 | 2006 | 35 | 0.020 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2006 | 320 | 0.020 |
Why?
|
| Epididymis | 1 | 2005 | 10 | 0.020 |
Why?
|
| Retroperitoneal Space | 1 | 2005 | 7 | 0.020 |
Why?
|
| Sympatholytics | 1 | 2005 | 11 | 0.020 |
Why?
|
| Mesentery | 1 | 2005 | 17 | 0.020 |
Why?
|
| Infusions, Parenteral | 1 | 2005 | 47 | 0.020 |
Why?
|
| Groin | 1 | 2005 | 11 | 0.020 |
Why?
|
| Oxidopamine | 1 | 2005 | 42 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2006 | 710 | 0.020 |
Why?
|
| Sympathomimetics | 1 | 2005 | 16 | 0.020 |
Why?
|
| Infusion Pumps | 1 | 2005 | 39 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2006 | 562 | 0.020 |
Why?
|
| Thermogenesis | 1 | 2004 | 5 | 0.010 |
Why?
|
| Insulin | 1 | 2007 | 619 | 0.010 |
Why?
|
| Testis | 1 | 2004 | 37 | 0.010 |
Why?
|
| Eating | 1 | 2004 | 119 | 0.010 |
Why?
|
| Mice, Knockout | 1 | 2007 | 1692 | 0.010 |
Why?
|
| Recombinant Proteins | 1 | 2005 | 742 | 0.010 |
Why?
|
| Uncoupling Protein 1 | 1 | 2002 | 1 | 0.010 |
Why?
|
| Orchiectomy | 1 | 2002 | 25 | 0.010 |
Why?
|
| Body Weight | 1 | 2004 | 554 | 0.010 |
Why?
|
| Ion Channels | 1 | 2002 | 72 | 0.010 |
Why?
|
| Seasons | 1 | 2002 | 129 | 0.010 |
Why?
|
| Mitochondrial Proteins | 1 | 2002 | 113 | 0.010 |
Why?
|
| Time Factors | 1 | 2006 | 4655 | 0.010 |
Why?
|